Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Europe Single-Cell Multi-Omics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
The Europe single-cell multi-omics market was valued at $0.35 billion in 2023 and is expected to reach $1.71 billion by 2033, growing at a CAGR of 17.23% during the forecast period 2023-2033. The market experiences growth due to several factors, including the increasing prevalence of large-scale genomics studies utilizing single-cell RNA sequencing (Sc-RNA), a shift towards personalized medicine using the single-cell multi-omics approach in disease screening and diagnostics, and the rising adoption of single-cell multi-omics in drug development.
Market Introduction
The Europe Single-Cell Multi-Omics Market is experiencing significant growth due to the advancements in genomics research and the increasing adoption of personalized healthcare. Researchers are leveraging single-cell multi-omics technologies to gain deeper insights into the molecular mechanisms of diseases, resulting in more precise diagnostics and treatments. Furthermore, these technologies are revolutionizing drug development by enabling highly targeted therapeutic approaches. Europe, with its robust healthcare infrastructure and research capabilities, is at the forefront of embracing single-cell multi-omics. Collaborations among academic institutions, biotech companies, and healthcare entities are driving innovation and expanding the scope of applications for these cutting-edge technologies, contributing to the market's expansion.
Market Segmentation
Segmentation 1: by Country
- Germany
- U.K.
- France
- Italy
- Spain
- Rest-of-Europe
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence. Some of the prominent names in this market are:
- Menarini Group
- QIAGEN NV
- Rarecells Diagnostics
- Scipio Bioscience
- Singleron Biotechnologies
Key Attributes
| Report Attribute | Details |
| No. of Pages | 89 |
| Forecast Period | 2023-2033 |
| Estimated Market Value (USD) in 2023 | $0.35 Billion |
| Forecasted Market Value (USD) by 2033 | $1.71 Billion |
| Compound Annual Growth Rate | 17.2% |
| Regions Covered | Europe |
Business Drivers
- Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (SC-RNA)
- Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
- Increasing Use of Single-Cell Multi-Omics for Drug Development
- Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics
Business Restraints
- High Cost of Single-Cell Analysis and Sequencing
- Limited Availability of Large Online Data Storage and Analysis Platforms
Business Opportunities
- Expansion into New Research Applications, such as Single-Cell Metabolomics
- Increasing Adoption of Genomic-based Medicine in Emerging Nations
For more information about this report visit https://www.researchandmarkets.com/r/i6y0b8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
